CN101914503B - 犬瘟热弱毒疫苗株及其应用 - Google Patents
犬瘟热弱毒疫苗株及其应用 Download PDFInfo
- Publication number
- CN101914503B CN101914503B CN2010102449642A CN201010244964A CN101914503B CN 101914503 B CN101914503 B CN 101914503B CN 2010102449642 A CN2010102449642 A CN 2010102449642A CN 201010244964 A CN201010244964 A CN 201010244964A CN 101914503 B CN101914503 B CN 101914503B
- Authority
- CN
- China
- Prior art keywords
- cdv
- strain
- canine distemper
- virus
- attenuated vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940031567 attenuated vaccine Drugs 0.000 title claims abstract description 19
- 208000000655 Distemper Diseases 0.000 title claims abstract description 17
- 208000014058 canine distemper Diseases 0.000 title claims abstract description 17
- 241000712083 Canine morbillivirus Species 0.000 claims abstract description 35
- 229960005486 vaccine Drugs 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 6
- 230000000813 microbial effect Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 241000282465 Canis Species 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000005847 immunogenicity Effects 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 238000010367 cloning Methods 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 229940031551 inactivated vaccine Drugs 0.000 abstract description 2
- 230000002045 lasting effect Effects 0.000 abstract description 2
- 241000700605 Viruses Species 0.000 description 54
- 241000282472 Canis lupus familiaris Species 0.000 description 43
- 238000012360 testing method Methods 0.000 description 24
- 239000002574 poison Substances 0.000 description 18
- 231100000614 poison Toxicity 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 230000003612 virological effect Effects 0.000 description 16
- 238000011081 inoculation Methods 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000001018 virulence Effects 0.000 description 6
- 230000000877 morphologic effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010011732 Cyst Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 101710085938 Matrix protein Proteins 0.000 description 4
- 101710127721 Membrane protein Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 208000031513 cyst Diseases 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 241000701931 Canine parvovirus Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000003501 vero cell Anatomy 0.000 description 3
- 239000005723 virus inoculator Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010037742 Rabies Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000024835 cytogamy Effects 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 229940125575 vaccine candidate Drugs 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
- 241000282452 Ailuropoda melanoleuca Species 0.000 description 1
- 241000282455 Ailurus fulgens Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241001466804 Carnivora Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 241000282675 Lagothrix Species 0.000 description 1
- 241001508687 Mustela erminea Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 241000283216 Phocidae Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 231100000645 Reed–Muench method Toxicity 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000002546 agglutinic effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 230000002477 vacuolizing effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000003474 viral inclusion body Anatomy 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102449642A CN101914503B (zh) | 2010-07-30 | 2010-07-30 | 犬瘟热弱毒疫苗株及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102449642A CN101914503B (zh) | 2010-07-30 | 2010-07-30 | 犬瘟热弱毒疫苗株及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101914503A CN101914503A (zh) | 2010-12-15 |
CN101914503B true CN101914503B (zh) | 2012-04-18 |
Family
ID=43322149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102449642A Expired - Fee Related CN101914503B (zh) | 2010-07-30 | 2010-07-30 | 犬瘟热弱毒疫苗株及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101914503B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102839158A (zh) * | 2012-08-29 | 2012-12-26 | 杨盛华 | 犬瘟热减毒疫苗株及医用用途 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107881169A (zh) * | 2016-09-29 | 2018-04-06 | 上海吉玛制药技术有限公司 | 预防或治疗犬瘟热的寡聚核酸组合及其应用 |
CN107158370B (zh) * | 2017-05-16 | 2020-04-17 | 中国农业科学院特产研究所 | 貉犬瘟热冻干活疫苗及其制备方法和应用 |
CN107236715B (zh) * | 2017-05-16 | 2020-01-14 | 中国农业科学院特产研究所 | 貉犬瘟热病毒弱毒疫苗株及其在制备貉犬瘟热活疫苗中的用途 |
CN107115525B (zh) * | 2017-05-16 | 2019-11-26 | 中国农业科学院特产研究所 | 貉犬瘟热活疫苗及其制备方法和应用 |
CN108486068A (zh) * | 2018-04-27 | 2018-09-04 | 青岛农业大学 | 一种犬瘟热弱毒株及其应用 |
CN108586585A (zh) * | 2018-04-27 | 2018-09-28 | 青岛农业大学 | 一种犬瘟热基因工程亚单位疫苗 |
CN112522217B (zh) * | 2019-09-18 | 2022-06-21 | 普莱柯生物工程股份有限公司 | 一种犬瘟热弱毒株及其制备的疫苗组合物和应用 |
CN112251416B (zh) * | 2020-10-20 | 2022-06-10 | 辽宁益康生物股份有限公司 | 一种犬瘟热病毒疫苗株、疫苗及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3080291A (en) * | 1960-06-10 | 1963-03-05 | Jensen Salsberg Lab Inc | Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom |
US3138531A (en) * | 1961-07-12 | 1964-06-23 | Lilly Co Eli | Canine distemper vaccine |
CN1117081A (zh) * | 1995-03-16 | 1996-02-21 | 高云 | 犬瘟热狂犬病细小病毒三联活疫苗、毒种及制造方法 |
CN1679931A (zh) * | 2004-03-11 | 2005-10-12 | 科米药物国际株式会社 | 在韩国分离的犬瘟热病毒和使用该病毒的重组疫苗 |
CN1876181A (zh) * | 2006-04-21 | 2006-12-13 | 中国人民解放军军事医学科学院军事兽医研究所 | 犬科动物重要疫病系列弱毒联合疫苗制剂及制备工艺 |
CN101612396A (zh) * | 2009-07-17 | 2009-12-30 | 齐鲁动物保健品有限公司 | 一种犬瘟热活疫苗及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008032796A1 (fr) * | 2006-09-13 | 2008-03-20 | Nippon Zenyaku Kogyo Co., Ltd. | Nouveau vaccin canin |
-
2010
- 2010-07-30 CN CN2010102449642A patent/CN101914503B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3080291A (en) * | 1960-06-10 | 1963-03-05 | Jensen Salsberg Lab Inc | Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom |
US3138531A (en) * | 1961-07-12 | 1964-06-23 | Lilly Co Eli | Canine distemper vaccine |
CN1117081A (zh) * | 1995-03-16 | 1996-02-21 | 高云 | 犬瘟热狂犬病细小病毒三联活疫苗、毒种及制造方法 |
CN1679931A (zh) * | 2004-03-11 | 2005-10-12 | 科米药物国际株式会社 | 在韩国分离的犬瘟热病毒和使用该病毒的重组疫苗 |
CN1876181A (zh) * | 2006-04-21 | 2006-12-13 | 中国人民解放军军事医学科学院军事兽医研究所 | 犬科动物重要疫病系列弱毒联合疫苗制剂及制备工艺 |
CN101612396A (zh) * | 2009-07-17 | 2009-12-30 | 齐鲁动物保健品有限公司 | 一种犬瘟热活疫苗及其制备方法 |
Non-Patent Citations (5)
Title |
---|
何洪彬,夏咸柱.犬瘟热的诊断及其预防免疫的研究进展.《动物医学进展》.2001,第22卷(第1期),12-15. * |
叶俊华 等.几种犬瘟热弱毒疫苗免疫效果比较研究.《江西畜牧兽医杂志》.2003,(第2期),37-38. * |
李惠敏.犬瘟热病毒的分离、鉴定及其抗原蛋白的研究.《四川农业大学硕士学位论文》.2006,全文. * |
欧阳俊,余杰.犬瘟热诊断和防制研究进展.《中国工作犬业》.2007,(第5期),15-17. * |
王凤雪 等.犬瘟热疫苗株CDV_3核蛋白基因全序列测序及分析.《特产研究》.2007,(第4期),7-10. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102839158A (zh) * | 2012-08-29 | 2012-12-26 | 杨盛华 | 犬瘟热减毒疫苗株及医用用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101914503A (zh) | 2010-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101914503B (zh) | 犬瘟热弱毒疫苗株及其应用 | |
CN102994458B (zh) | 猪伪狂犬病病毒强毒株、其基因缺失疫苗株及其应用 | |
CN101935637B (zh) | 鸡传染性法氏囊病病毒重组弱毒疫苗株及其应用 | |
CN113337478B (zh) | 一株猫细小病毒毒株及其应用 | |
CN103923884A (zh) | 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 | |
CN107384874A (zh) | 伪狂犬病毒流行株gI/gE基因缺失突变株及构建和应用 | |
CN106591242A (zh) | 一株犬细小病毒毒株cpv‑yh及其应用 | |
CN102363769A (zh) | 鸡马立克氏病毒Meq基因缺失疫苗株,其构建方法及应用 | |
CN101905021A (zh) | 犬瘟热、犬细小病毒和犬腺病毒i型三联活疫苗及其制备方法 | |
CN110607285A (zh) | 一种耐热的血清4型禽腺病毒基因工程疫苗候选株及其构建方法 | |
CN111593027B (zh) | 一种草鱼呼肠孤病毒ⅱ型弱毒株及其应用 | |
CN101942419B (zh) | 犬细小病毒弱毒疫苗株及其应用 | |
CN101914502B (zh) | Ⅰ型犬腺病毒弱毒疫苗株及其应用 | |
CN104059889A (zh) | 伪狂犬病病毒变异株双基因缺失毒株及其构建方法和应用 | |
CN101215576A (zh) | 兔病毒性出血症病毒衣壳蛋白基因重组杆状病毒及疫苗 | |
CN104928260A (zh) | 一种牛传染性鼻气管炎病毒ibrv-jn03分离株及其应用 | |
CN101979502B (zh) | 表达o型口蹄疫病毒vp1基因的重组布鲁氏菌及其疫苗的生产方法 | |
CN103773739B (zh) | 一种猫泛白细胞减少症病毒减毒疫苗株及其应用 | |
CN104004697B (zh) | 一种单基因缺失粗糙型布鲁氏菌及其疫苗的生产方法 | |
CN101979503B (zh) | 表达Asia I型口蹄疫病毒VP1基因的重组布鲁氏菌及其疫苗的生产方法 | |
CN103937817A (zh) | 鸡新城疫病毒yt毒株、其全基因组序列及其应用 | |
CN104419686A (zh) | 重组PRRS病毒HV-nsp9及其应用 | |
CN114921422B (zh) | 一种犬源猫细小病毒分离株及其应用 | |
CN102363770A (zh) | 融合表达猪圆环病毒2型Cap蛋白和生长抑素的重组杆状病毒及其亚单位疫苗 | |
CN102337250A (zh) | 牛传染性鼻气管炎病毒毒株及制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Dafei Inventor after: Zhang Hongying Inventor after: Qu Liandong Inventor after: Liu Chunguo Inventor after: Wang Mouping Inventor before: Liu Dafei Inventor before: Zhang Hongying Inventor before: Qu Liandong Inventor before: Wang Mouping Inventor before: Liu Likui |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU DAFEI ZHANG HONGYING QU LIANDONG WANG MOUPING LIU LIKUI TO: LIU DAFEI ZHANG HONGYING QU LIANDONG LIU CHUNGUO WANG MOUPING |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: Name of the third inventor Correct: Qu Liandong False: Qu Liandong Number: 16 Volume: 28 |
|
CI02 | Correction of invention patent application |
Correction item: Third inventor Correct: Qu Liandong False: Qu Liandong Number: 16 Page: The title page Volume: 28 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20170730 |